MENNINI, F. S.; PAOLETTI, M.; BINI, C.; MARCELLUSI, A.; FALCONE, M.; ANDREONI, M. Cost-utility analysis of ceftolozane/tazobactam vs meropenem in patients with hospital-acquired pneumonia (HABP) or ventilator-associated pneumonia (VABP). Global and Regional Health Technology Assessment, [S. l.], v. 9, n. 1, p. 45–57, 2022. DOI: 10.33393/grhta.2022.2287. Disponível em: https://journals.aboutscience.eu/index.php/grhta/article/view/2287. Acesso em: 19 apr. 2024.